| ¡ Salvemos Moya! FB Avila, J Hernández, A Marchuet, C Alcaraz, E Barelles, M Eleuterio, ... X Congreso de Conservación y Restauración de Bienes Culturales: Cuenca, 29 …, 1994 | | 1994 |
| | PREVENTION OF PROSTATE CANCER J HERNANDEZ, I THOMPSONJR Comprehensive Textbook of Genitourinary Oncology, 79, 2006 | | 2006 |
| 1050: Pre-and Post-Surgery Factors Affecting the Outcomes of Patients with Intermediate Risk Prostate Cancer CL Amling, L Sun, JW Moul, Y Chen, DG McLeod, TF Donahue, L Kusuda, ... The Journal of Urology, 2004 | | 2004 |
| 1184: How Long can Radical Prostatectomy (RP) Safely be Delayed? CPDR'S Experiences From 3324 Cases JW Moul, CL Amling, Y Chen, DG McLeod, TF Donahue, L Kusuda, ... The Journal of Urology, 2004 | 13 | 2004 |
| 1414: Aggressive Prostate Cancer is Associated with Nucleotide Variants of the Semaphorin 3F Gene SL Naylor, X He, RH Xiang, DK Garcia, ED Canby-Hagino, J Baillargeon, ... The Journal of Urology 173 (4S), 383-383, 2005 | | 2005 |
| 1480: The Association of Body Mass Index and Serum Prostate Specific Antigen Levels in a Population-Based Study J Hernandez, J Baillargeon, B Pollock, AR Kristal, P Bradshaw, JW Basler, ... The Journal of Urology, 2005 | 2 | 2005 |
| 1873: External Validation of the Prostate Cancer Prevention Trial Risk Calculator in a Screened Population D Parekh, AB Reed, DP Ankerst, BA Higgins, J Hernandez, ... The Journal of Urology, 2007 | | 2007 |
| 18q copy number variation in primary prostate tumors as a predictor of long-term outcome KA Ashcraft, TL Johnson-Pais, JAL Gelfond, J Hernandez, IM Thompson, ... Cancer Research 76 (14 Supplement), 4949-4949, 2016 | | 2016 |
| 404: P53 ARG72PRO Single Nucleotide Polymorphism (SNP) is Associated with Increased Risk for Prostate Cancer Among African American Men J Hernandez, I Batie, TL Johnson-Pais, IM Thompson, RJ Leach The Journal of Urology, 2005 | | 2005 |
| 445: Prostate Cancer Mortality After Radical Prostatectomy or Radiation Therapy in Men with Clinically Localized Prostate Cancer H Wu, JW Moul, L Sun, DG McLeod, CL Amling, TF Donahue, L Kusuda, ... The Journal of Urology 171 (4s), 118-118, 2004 | | 2004 |
| 446: Contemporary Experience with Hormone Refractory Prostate Cancer (HRPC-Stage D3) in the PSA-Era: Report from the DOD CPDR National Database Y Chen, JW Maul, L Sun, DG McLeod, CL Amling, TF Donahue, L Kusuda, ... The Journal of Urology, 2004 | | 2004 |
| 470: Changing Face of Prostate Cancer in the PSA-Era: Results from the CPDR National Database A Chung, L Sun, CA Carter, JW Moul, X Zhao, DG McLeod, CL Amling, ... The Journal of Urology, 2004 | | 2004 |
| 472: Prostate Cancer in Men Less than or Equal to 40 Years of Age During The PSA Era WJ Sexton, RC McDonough, J Hernandez, L Sun, JW Moul, CL Amling, ... The Journal of Urology 171 (4s), 126-126, 2004 | | 2004 |
| 990 SPANXB2 EXPRESSION INCREASES PROSTATE CANCER AGGRESSIVITY: A NEW VIEW OF STROMAL-EPITHELIAL CELL INTERACTION H Li, ED Kou, J Hernandez, S Ressler, A Sreekumar, G Ayala, D Rowley, ... The Journal of Urology, 2013 | | 2013 |
| A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial–mesenchymal cell reprogramming and cancer progression H Roca, M Pande, JS Huo, J Hernandez, JD Cavalcoli, KJ Pienta, ... BMC systems biology 8 (1), 29, 2014 | 13 | 2014 |
| A case-control study of fifty-four biomarkers of prostate cancer DJ Parekh, PT Schraudenbach, DP Ankerst, AE Lokshin, J Baillargeon, ... The Journal of Urology 4 (179), 605, 2008 | | 2008 |
| A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts DP Ankerst, J Straubinger, K Selig, L Guerrios, A De Hoedt, J Hernandez, ... European urology 74 (2), 197-203, 2018 | 12 | 2018 |
| A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy HA Michaud, T Gomard, L Gros, K Thiolon, R Nasser, C Jacquet, ... PLoS pathogens 6 (6), e1000948, 2010 | 42 | 2010 |
| A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray S Hawley, L Fazli, JK McKenney, J Simko, D Troyer, M Nicolas, ... Advances in anatomic pathology 20 (1), 39, 2013 | 20 | 2013 |
| A monoclonal antibody-based transient immunotherapy prevents viral-induced cancer by promoting a protective endogenous immune response HA Michaud, L Gros, AC Julio, C Jacquet, J Hernandez, M Piechaczyk, ... BULLETIN DU CANCER 95, S54-S54, 2008 | | 2008 |
